[Drug-resistance Acinetobacter baumannii infection in burn patients: current situation and countermeasure]
1Department of Burns and Plastic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Abstract:
Infections caused by Acinetobacter baumannii (AB) have emerged as a knotty clinical problem in the burn wards due to its omni-resistance to antibiotics and high prevalence. Although our knowledge in regard to the pathogenesis and the resistance mechanisms of AB is increasing, the available treatment remains much limited. Measures to effectively control nosocomial infection are warranted. Meanwhile, development of novel therapeutic agents or combination of antibiotics should be considered.
Insights
Acinetobacter baumannii (AB) infections are a growing problem in burn units due to widespread antibiotic resistance. New treatments and infection control measures are urgently needed to combat this resilient pathogen.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- Acinetobacter baumannii (AB) poses a significant challenge in healthcare settings, particularly burn units.
- This bacterium exhibits extensive resistance to multiple antibiotics, complicating treatment options.
Purpose of the Study:
- To highlight the clinical problem of Acinetobacter baumannii infections in burn wards.
- To emphasize the need for improved control measures and novel therapeutic strategies against AB.
Main Methods:
- Review of current literature on Acinetobacter baumannii pathogenesis and resistance.
- Analysis of treatment limitations and infection control challenges.
Main Results:
- Acinetobacter baumannii infections are prevalent and difficult to treat due to omni-resistance.
- Existing knowledge on AB pathogenesis and resistance mechanisms is growing but treatment options remain limited.
Conclusions:
- Effective control of nosocomial infections caused by Acinetobacter baumannii is crucial.
- Development of novel therapeutic agents or antibiotic combinations is necessary to address treatment challenges.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

